B-cell prolymphocytic leukemia epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (6 intermediate revisions by 2 users not shown) | |||
| Line 4: | Line 4: | ||
== Overview == | == Overview == | ||
The incidence of B-cell prolymphocytic leukemia is 1% of lymphocytic leukemias. B-cell prolymphocytic leukemia affects | The incidence of [[B cell|B-cell]] [[prolymphocytic leukemia]] is 1% of [[Leukemias|lymphocytic leukemias]]. [[B-cell]] [[prolymphocytic leukemia]] affects [[males]] and [[Female|females]] equally. | ||
==Epidemiology and demographics== | ==Epidemiology and demographics== | ||
===Age=== | ===Age=== | ||
* B-cell prolymphocytic leukemia is around 65-69 years | * The median age for the development of [[B cell|B-cell]] [[prolymphocytic leukemia]] is around 65-69 years of age.<ref name="B-PLL">{{cite web | title = National cancer institute| url = http://seer.cancer.gov/seertools/hemelymph/51f6cf58e3e27c3994bd53f9/ }}</ref><ref name="pmid3487341">{{cite journal |vauthors=Melo JV, Catovsky D, Galton DA |title=The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. I. Clinical and laboratory features of 300 patients and characterization of an intermediate group |journal=Br. J. Haematol. |volume=63 |issue=2 |pages=377–87 |date=June 1986 |pmid=3487341 |doi= |url=}}</ref> | ||
===Incidence=== | ===Incidence=== | ||
* B-cell prolymphocytic leukemia | * The incidence of [[B cell|B-cell]] [[prolymphocytic leukemia]] is 1% of [[Leukemias|lymphocytic leukemias]].<ref name="pmid18064533">{{cite journal |vauthors=Yamamoto JF, Goodman MT |title=Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002 |journal=Cancer Causes Control |volume=19 |issue=4 |pages=379–90 |date=May 2008 |pmid=18064533 |doi=10.1007/s10552-007-9097-2 |url=}}</ref> | ||
<ref name="pmid18064533">{{cite journal |vauthors=Yamamoto JF, Goodman MT |title=Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002 |journal=Cancer Causes Control |volume=19 |issue=4 |pages=379–90 |date=May 2008 |pmid=18064533 |doi=10.1007/s10552-007-9097-2 |url=}}</ref> | |||
===Gender=== | ===Gender=== | ||
*There is no gender predilection.<ref name="pmid18064533">{{cite journal |vauthors=Yamamoto JF, Goodman MT |title=Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002 |journal=Cancer Causes Control |volume=19 |issue=4 |pages=379–90 |date=May 2008 |pmid=18064533 |doi=10.1007/s10552-007-9097-2 |url=}}</ref> | *There is no [[Gender-based medicine|gender]] predilection.<ref name="pmid18064533">{{cite journal |vauthors=Yamamoto JF, Goodman MT |title=Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002 |journal=Cancer Causes Control |volume=19 |issue=4 |pages=379–90 |date=May 2008 |pmid=18064533 |doi=10.1007/s10552-007-9097-2 |url=}}</ref> | ||
===Survival=== | ===Survival=== | ||
* | * The duration of [[Survival analysis|median survival]] for this [[disease]] is 30-50 months. | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Leukemia]] | |||
[[Category:Disease]] | |||
[[Category:Hematology]] | |||
[[Category:Types of cancer]] | |||
[[Category:Oncology]] | |||
[[Category: | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | |||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Hematology]] | |||
[[Category:Immunology]] | |||
Latest revision as of 19:24, 8 April 2019
|
B-cell prolymphocytic leukemia |
|
Differentiating B-cell prolymphocytic leukemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
B-cell prolymphocytic leukemia epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of B-cell prolymphocytic leukemia epidemiology and demographics |
|
FDA on B-cell prolymphocytic leukemia epidemiology and demographics |
|
CDC on B-cell prolymphocytic leukemia epidemiology and demographics |
|
B-cell prolymphocytic leukemia epidemiology and demographics in the news |
|
Blogs on B-cell prolymphocytic leukemia epidemiology and demographics |
|
Directions to Hospitals Treating B-cell prolymphocytic leukemia |
|
Risk calculators and risk factors for B-cell prolymphocytic leukemia epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Qurrat-ul-ain Abid, M.D.[2],Carlos A Lopez, M.D. [3]
Overview
The incidence of B-cell prolymphocytic leukemia is 1% of lymphocytic leukemias. B-cell prolymphocytic leukemia affects males and females equally.
Epidemiology and demographics
Age
- The median age for the development of B-cell prolymphocytic leukemia is around 65-69 years of age.[1][2]
Incidence
- The incidence of B-cell prolymphocytic leukemia is 1% of lymphocytic leukemias.[3]
Gender
Survival
- The duration of median survival for this disease is 30-50 months.
References
- ↑ "National cancer institute".
- ↑ Melo JV, Catovsky D, Galton DA (June 1986). "The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. I. Clinical and laboratory features of 300 patients and characterization of an intermediate group". Br. J. Haematol. 63 (2): 377–87. PMID 3487341.
- ↑ 3.0 3.1 Yamamoto JF, Goodman MT (May 2008). "Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002". Cancer Causes Control. 19 (4): 379–90. doi:10.1007/s10552-007-9097-2. PMID 18064533.